Armistice Capital, LLC Prothena Corp Public LTD CO Transaction History
Armistice Capital, LLC
- $7.69 Billion
- Q2 2024
A detailed history of Armistice Capital, LLC transactions in Prothena Corp Public LTD CO stock. As of the latest transaction made, Armistice Capital, LLC holds 1,560,000 shares of PRTA stock, worth $31.3 Million. This represents 0.42% of its overall portfolio holdings.
Number of Shares
1,560,000
Previous 1,096,000
42.34%
Holding current value
$31.3 Million
Previous $27.1 Million
18.61%
% of portfolio
0.42%
Previous 0.37%
Shares
3 transactions
Others Institutions Holding PRTA
# of Institutions
182Shares Held
42.7MCall Options Held
77.7KPut Options Held
92.7K-
Eco R1 Capital, LLC San Francisco, CA11.6MShares$232 Million8.45% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD4.24MShares$84.9 Million0.01% of portfolio
-
Black Rock Inc. New York, NY3.86MShares$77.3 Million0.0% of portfolio
-
Wellington Management Group LLP Boston, MA3.64MShares$72.9 Million0.01% of portfolio
-
State Street Corp Boston, MA1.93MShares$38.7 Million0.0% of portfolio
About PROTHENA CORP PUBLIC LTD CO
- Ticker PRTA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 46,922,800
- Market Cap $940M
- Description
- Prothena Corporation plc, a late-stage clinical company, focuses on discovery and development of novel therapies for life-threatening diseases in the United States. The company is involved in developing Birtamimab, an investigational humanized antibody that is in Phase III clinical trial for the treatment of AL amyloidosis; Prasinezumab, a human...